BACKGROUND AND STUDY AIM: Endoscopic retrograde cholangiopancreatography (ERCP) has been shown to be overall effective and safe in children, but its performance characteristics and safety profile have not been specifically evaluated according to age. We aim to compare the indications, findings, interventions, and safety outcomes of ERCP across pediatric age groups. METHODS: A retrospective cross-sectional study of pediatric patients (ages 17 or below) who underwent ERCP between October 1998 and April 2011 at a tertiary-care academic center. Data on indications, findings, technical success, and adverse events of ERCP were collected and compared according to age groups (0-6, 7-12, or 13-17 years). RESULTS: There were 289 procedures performed in 154 children (mean age, 11.5 years). The number of patients undergoing ERCP increased with age; teenagers constituted the largest group (52.6%) and had the most procedures (49.8%). Children aged 0-6 years had an equal distribution of biliary and pancreatic cases; children aged 7-12 years had predominantly pancreatic indications. Most procedures in teenagers were for biliary indications. Overall, the technical success rates of ERCPs were similar across age groups (P=0.661). Seventeen adverse events (5.9% of procedures) were identified: post-procedure pancreatitis (12 cases; 4.2%), hypoxia (3; 1.0%), and hemorrhage (2; 0.7%). The youngest group had more adverse events (12.0%, compared to 6.3 and 2.1% in other groups; P=0.049), mostly due to mild pancreatitis. CONCLUSION: ERCP is generally safe in the pediatric population, although the risk of mild post-procedure pancreatitis may be higher among the youngest children.
BACKGROUND AND STUDY AIM: Endoscopic retrograde cholangiopancreatography (ERCP) has been shown to be overall effective and safe in children, but its performance characteristics and safety profile have not been specifically evaluated according to age. We aim to compare the indications, findings, interventions, and safety outcomes of ERCP across pediatric age groups. METHODS: A retrospective cross-sectional study of pediatric patients (ages 17 or below) who underwent ERCP between October 1998 and April 2011 at a tertiary-care academic center. Data on indications, findings, technical success, and adverse events of ERCP were collected and compared according to age groups (0-6, 7-12, or 13-17 years). RESULTS: There were 289 procedures performed in 154 children (mean age, 11.5 years). The number of patients undergoing ERCP increased with age; teenagers constituted the largest group (52.6%) and had the most procedures (49.8%). Children aged 0-6 years had an equal distribution of biliary and pancreatic cases; children aged 7-12 years had predominantly pancreatic indications. Most procedures in teenagers were for biliary indications. Overall, the technical success rates of ERCPs were similar across age groups (P=0.661). Seventeen adverse events (5.9% of procedures) were identified: post-procedure pancreatitis (12 cases; 4.2%), hypoxia (3; 1.0%), and hemorrhage (2; 0.7%). The youngest group had more adverse events (12.0%, compared to 6.3 and 2.1% in other groups; P=0.049), mostly due to mild pancreatitis. CONCLUSION: ERCP is generally safe in the pediatric population, although the risk of mild post-procedure pancreatitis may be higher among the youngest children.
Authors: R Rocca; F Castellino; M Daperno; G Masoero; R Sostegni; E Ercole; A Lavagna; C Barbera; F Canavese; A Pera Journal: Dig Liver Dis Date: 2005-05 Impact factor: 4.088
Authors: Chi-Liang Cheng; Stuart Sherman; James L Watkins; Jeffrey Barnett; Martin Freeman; Joseph Geenen; Michael Ryan; Harrison Parker; James T Frakes; Evan L Fogel; William B Silverman; Kulwinder S Dua; Giuseppe Aliperti; Paul Yakshe; Michael Uzer; Whitney Jones; John Goff; Laura Lazzell-Pannell; Abdullah Rashdan; M'hamed Temkit; Glen A Lehman Journal: Am J Gastroenterol Date: 2006-01 Impact factor: 10.864
Authors: I L Vegting; M M Tabbers; J A J M Taminiau; D C Aronson; M A Benninga; E A J Rauws Journal: J Pediatr Gastroenterol Nutr Date: 2009-01 Impact factor: 2.839
Authors: Maisam Abu-El-Haija; Soma Kumar; Jose Antonio Quiros; Keshawadhana Balakrishnan; Bradley Barth; Samuel Bitton; John F Eisses; Elsie Jazmin Foglio; Victor Fox; Denease Francis; Alvin Jay Freeman; Tanja Gonska; Amit S Grover; Sohail Z Husain; Rakesh Kumar; Sameer Lapsia; Tom Lin; Quin Y Liu; Asim Maqbool; Zachary M Sellers; Flora Szabo; Aliye Uc; Steven L Werlin; Veronique D Morinville Journal: J Pediatr Gastroenterol Nutr Date: 2018-01 Impact factor: 2.839
Authors: Margaret G Keane; Mayur Kumar; Natascha Cieplik; Douglas Thorburn; Gavin J Johnson; George J Webster; Michael H Chapman; Keith J Lindley; Stephen P Pereira Journal: BMC Pediatr Date: 2018-02-09 Impact factor: 2.125
Authors: Radan Keil; Jiří Drábek; Jindra Lochmannová; Jan Šťovíček; Petra Koptová; Martin Wasserbauer; Barbora Frýbová; Jiří Šnajdauf; Jan Matouš; Radana Kotalová; Michal Rygl; Štěpán Hlava Journal: PLoS One Date: 2019-01-17 Impact factor: 3.240